Physician profile
Eric H Steinberg
NPI 1477621076
$3,072.87
in general payments reported to CMS, 2019-2025
22 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,407 · 2020: $530 · 2021: $474 · 2022: $297 · 2023: $204 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $400.17 | 2019-2023 | Farxiga |
| Amgen INC. | $361.77 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $297.84 | 2019-2023 | Eliquis |
| Janssen Pharmaceuticals, INC | $289.98 | 2019-2021 | |
| Pfizer INC. | $288.42 | 2019-2023 | |
| Abbott Laboratories | $198.96 | 2019-2020 | |
| Amarin Pharma, INC. | $188.35 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.10 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $134.91 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $123.38 | 2025 | |
| Esperion Therapeutics, INC. | $114.82 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $72.24 | 2019-2021 | |
| Lantheus Medical Imaging, INC. | $69.38 | 2022-2023 | Definity |
| Edwards Lifesciences Corporation | $65.91 | 2019 | |
| Merck Sharp & Dohme LLC | $61.65 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $57.58 | 2019 | |
| Alnylam Pharmaceuticals INC. | $47.45 | 2019 | |
| Astellas Pharma US INC | $39.25 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.30 | 2025 | Lifevest |
| Janssen Scientific Affairs, LLC | $35.42 | 2019 | |
| Bardy Diagnostics, INC. | $19.00 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $17.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.